Market's view on Diaceutics
Published on April 2024
- A Stock watcher expressed frustration over the inaccessibility of brokers’ research reports on DXRX for private investors, a common issue across many quoted companies.
- Concerns were raised about DXRX’s outdated and cheap-looking website compared to competitors, which might deter potential investors.
- A positive note was shared about the CFO, Nick Roberts, who has a history of affiliating with successful companies, raising expectations for his performance at DXRX.
- Anticipation for a significant company event with a forthcoming trading update was highlighted.
- There are predictions for a possible takeover of DXRX due to its perceived strong market position, valuable connections, and financial resources.
- Discussions included observations on DXRX’s potential for profit generation and corporate growth, reflecting a general optimism about the company’s trajectory.